Resilience
Entrepreneurs and economic resilience
When large firms retrench, smaller companies often fill the gaps—and founder wellbeing shapes how long that recovery lasts.
Pharma AI
AI drug discovery is a multi-trillion waiting room problem
The money is not in prettier slides. It is in shrinking the decade between molecule and medicine—if trials and manufacturing keep up.
Clinics
The consumer longevity clinic boom is a services economy in a lab coat
Blood panels, memberships, and optimisation packages are building a retail layer on top of aging science—some rigorous, some theatre.
Diagnostics
Early detection is where AI and longevity share a balance sheet
Multi-cancer tests, imaging AI, and at-home sampling race to pull disease left on the timeline—where treatment is cheaper and lives are longer.
Monitoring
Continuous monitoring turns the body into a high-frequency market
Wearables, patches, and home devices generate streams of data. The money is in signal quality, clinical action, and trust—not step-count vanity.
Age-tech
Age-tech is the quiet multi-trillion demographic trade
Robotics, logistics, housing design, and workforce tools for societies that are getting older faster than their care systems can hire.
Regenerative
Regenerative medicine is a manufacturing and trust problem disguised as miracles
Cell therapies, tissue engineering, and repair biology promise rebuilt function. Scale, cost, and evidence decide whether it becomes a mass market.
Gene therapy
Gene therapy’s commercial path is paved with vectors, not slogans
One-time treatments, durable value arguments, and delivery science are rewriting how payers and biotech think about price.
Hospital AI
Hospital AI is a productivity market wearing a stethoscope
Documentation, imaging, operations, and decision support are where health systems will spend—because labour is scarce and errors are costly.
Nutrition
Precision nutrition wants to be a trillion-dollar habit business
Personalised food, CGM culture, and AI meal coaching chase the daily behaviours that still dominate healthspan.
Workplace
Workplace longevity benefits are HR’s new multi-decade arms race
Employers are rediscovering that healthspan is a productivity asset—and vendors are lining up to sell the stack.
Insurtech
Insurtech meets longevity: pricing longer lives without breaking the pool
Underwriting, prevention incentives, and AI risk models are rewriting life, health, and retirement products for a longer century.
Robotics
Home robotics and senior living are a real-estate-meets-AI stack
From fall response to logistics robots in care homes, machines enter the places where aging actually happens.
Brain health
Brain health is becoming its own economic sector
Dementia costs, cognitive performance markets, and neurotech are pulling mental longevity into the centre of the longevity economy.
Fertility
Fertility and reproductive longevity are a parallel trillion-dollar clock
Egg freezing, IVF innovation, male fertility, and menopause care sit beside aging science—and AI is already inside the lab.
Biomanufacturing
Biomanufacturing is the pick-and-shovel play under the longevity boom
Without factories, quality systems, and trained operators, advanced therapies remain slideware.
Platforms
Computational biology platforms are becoming the operating systems of R&D
Foundation models for molecules, cells, and literature are turning biology into a software-edged industry.
Capital
Longevity capital markets: from grants to growth equity without the cult
Venture, public biotech, sovereign funds, and family offices are building a financing stack for longer lives—discipline optional, unfortunately.
Data
Health data infrastructure is the hidden trillion under every AI promise
Interoperability, privacy, labelling, and secure compute decide whether medical AI is a demo or a utility.
Global
Asia’s aging middle class is a demand shock the longevity economy cannot ignore
Scale, speed of aging, and rising health spend make Asian markets decisive for AI-health and longevity business models.
Climate health
Climate-resilient health is the longevity economy’s outdoor risk factor
Heat, air quality, infectious shifts, and supply-chain shocks are health-market drivers—not only environmental headlines.